United Therapeutics Corporation (UTHR)
Market Closed
12 Jun, 20:00
$
545. 96
+0.56
+0.1027%
$
23.17B Market Cap
11.96 P/E Ratio
- Div Yield
451,800 Volume
24.04 Eps
$ 545.4
Previous Close 
Want to track UTHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
United Therapeutics Corporation (UTHR) Statistics
Valuation metrics
Market Cap 23.17B
Enterprise value 22.1B
Trailing P/E (ttm) 18.45
Forward P/E -
PEG ratio 2.32
Price/Sales (ttm) 7.31
Price/Book (mrq) 4.02
Enterprise Value/Revenue 6.97
Enterprise Value/EBITDA 12.9
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 355.69K
Average volume (90 days) 518.04K
Price summary
52-Week low 272.12
52-Week high 609.35
Beta -
50-Day moving average 569.43
200-Day moving average 521.32
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 23 Sep 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.41%
Operating margin 0.45%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 72.87
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 29.6
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 49.51
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 4.79%
Book value per share (mrq) 135.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
